Selected References
- Anderson J., et al. 2020. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report. Case reports in women’s health, 27, e00221. Advance online publication. https://doi.org/10.1016/j.crwh.2020.e00221.
- Clinical Solutions: Remdesivir monograph. Revised 5/7/2020. https://www.elsevier.com/__data/assets/pdf_file/0008/996767/Remdesivir-Drug-Monograph_28MAY2020.pdf
- Coronavirus (COVID-19) Update: FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment. 2020. U.S. Food and Drug Administration. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment
- Dornemann J, et al. 2017. First newborn baby to receive experimental therapies survives Ebola virus disease. J Infect Dis., 215:171–4.
- Gilead Sciences, Inc. 2020. Remdesivir product labeling. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=98b7e6bf-2668-4a61-a874-194eb674b15c&type=display
- Mulangu S, et al. 2019. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med., 381:2293–303.
- Naqvi, M, et al. Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19), Obstetrics & Gynecology. 2020. doi: 10.1097/AOG.0000000000004050
- Pierce-Williams RAM, et al. 2020. Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study. Am J Obstet Gynecol MFM. https://pubmed.ncbi.nlm.nih.gov/32391519/
